1. ALLA AKTIER
  2. NYHETER
  3. CHORDATE MEDICAL

Chordate Medical

Nyheter Chordate Medical Nyheter alla bolag

Invitation to live investor meeting with Chordate Medical 29 December at 14:00

On Thursday 29 December at 14:00, Chordate's CEO Anders Weilandt will present the Company, the rationale for the Rights Issue and further information on the Company's strategy and future plans. The presentation will be held in Swedish and will be broadcast live, hosted by Västra Hamnen Corporate Finance.

After the presentation, participants will have the opportunity to ask questions. The number of seats is limited, and the Company therefore recommends registering in advance to be assured of a seat. Registration for the investor meeting can be done via the link below.

Time: Thursday 29 December, 14:00 (2 p.m.)

Registration: https://attendee.gotowebinar.com/register/5852611762100083288

A recording of the broadcast will be available afterwards on Chordate's website and on the Västra Hamnen Corporate Finance YouTube-kanal.

For more information, please contact:
Anders Weilandt, CEO
anders.weilandt@chordate.com
Cell: +46 733-874277

About Chordate
Chordate Medical Holding AB (publ) is a medical technology company that has developed, patented and CE-marked a neuromodulation and drug-free treatment technology for chronic migraine and chronic nasal congestion (rhinitis), Kinetic Oscillation Stimulation (K.O.S). The K.O.S-treatment has clinically proven efficacy according to scientific studies. The company's products are available via distributors to clinics in the Nordic countries, Germany, the UK, Italy, Israel, and Saudi Arabia. Chordate Medical is listed on Nasdaq First North Growth Market Stockholm (ticker: CMH). Read more at chordate.com/en

The company's Certified Adviser on Nasdaq First North Growth Market Stockholm is Västra Hamnen Corporate Finance AB.

N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail.

Attachments
Invitation to live investor meeting with Chordate Medical 29 December at 14:00

Datum 2022-12-23, kl 08:30
Källa MFN
Bifogade filer
Invitation to live investor meeting with Chordate Medical 29 December at 14:00
Affiliate
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet